DIEP Flap Surgery and Intraabdominal Pressure

Sponsor
Aalborg University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05764577
Collaborator
(none)
13
1
9.2
1.4

Study Details

Study Description

Brief Summary

Aim: The primary aim of this study is to test if closure of the abdominal donor site increases the Intraabdominal Pressure (IAP) in women undergoing secondary Deep Inferior epigastric perforator (DIEP) flap breast reconstruction.

Materials and method: By an Unometer, attached to a standard catheter in the bladder, we measured the intravesical pressure as a surrogate marker for the IAP, at baseline, immediate after- and 24 hours after abdominal skin closure, for 13 patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: DIEP flap surgery

Study Design

Study Type:
Observational
Actual Enrollment :
13 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Intraabdominal Pressure Increases Peri-operatively in Patients Undergoing DIEP Flap Reconstruction: A Prospective Study Linking High IAP to Non-fatal Lung Embolism in One Patient
Actual Study Start Date :
Apr 19, 2021
Actual Primary Completion Date :
Nov 29, 2021
Actual Study Completion Date :
Jan 25, 2022

Arms and Interventions

Arm Intervention/Treatment
Surgical intervention

Participants who underwent secondary DIEP flap breast reconstruction

Procedure: DIEP flap surgery
Removal off the DIEP flap followed by closure of the rectus sheath and abdominal skin.

Outcome Measures

Primary Outcome Measures

  1. Changes from Baseline in intraabdominal pressure at timepoint immediate after- and 24 hours after abdominal skin closure. [Baseline, immediate after- and 24 hours after abdominal skin closure]

    : By an Unometer, attached to a standard catheter in the bladder, we measured the intravesical pressure as a surrogate marker for the IAP, at baseline, immediate after- and 24 hours after abdominal skin closure

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Females undergoing secondary DIEP flap breast reconstruction.

  • Performance status 1-2

Exclusion Criteria:
  • Performance status above 2.

  • Untreated hypertension or atrial fibrillation

Performance status evalutated using American Society of Anaesthesiologists' (ASA) classification of Physical Health.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University hospital Aalborg Aalborg North Jutland Denmark 9000

Sponsors and Collaborators

  • Aalborg University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nikolaj Warming, Principal investigator, Aalborg University Hospital
ClinicalTrials.gov Identifier:
NCT05764577
Other Study ID Numbers:
  • 2021-082
First Posted:
Mar 10, 2023
Last Update Posted:
Mar 10, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2023